Aerie Pharmaceuticals
Aerie Pharmaceuticals
Employees:
130
Market Cap:
$2.26 billion
Revenue:
$0.0
Net Income:
$-134.72 million
NASDAQ:
AERI

Aerie Pharmaceuticals (NASDAQ: AERI) is a publicly traded, clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aeries two lead product candidates are once-daily IOP-lowering therapies with novel mechanisms of action to treat patients with glaucoma or ocular hypertension. Wikipedia

Aerie Pharmaceuticals
Are you from Aerie Pharmaceuticals, Inc?

Aerie Pharmaceuticals (NASDAQ: AERI) is a publicly traded, clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. Aeries two lead product candidates are once-daily IOP-lowering therapies with novel mechanisms of action to treat patients with glaucoma or ocular hypertension. Wikipedia

Employees:
130
Market Cap:
$2.26 billion
Revenue:
$0.0
Net Income:
$-134.72 million
NASDAQ:
AERI

Jobs at Aerie Pharmaceuticals

There are no jobs at the current time